Get started Log in

SRNE — Sorrento Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
$0.17m
Enterprise Value
$68.79m
Revenue
$62.84m

Sorrento gains on completing early-stage study of oral COVID-19 drug
17/10/2022 14:27
Brief: Sorrento Successfully Completes Phase 1 Study And Is Proceeding To Implement Global Registrational Trials With Sti-1558
17/10/2022 14:14
Brief: Sorrento Therapeutics Inc Entered Into A Bridge Loan Agreement Pursuant To Which The Co Borrowed $41.7 Million From The Lender
30/09/2022 19:53
Brief: Sorrento Therapeutics Completes Enrollment Of Phase 2 Clinical Trial Of Resiniferatoxin (RTX) For Treatment Of Knee Pain In Moderate To Severe Osteoarthritis Of The Knee (OAK) Patients
26/09/2022 14:49
Brief: Sorrento Reports Positive Trial Results Utilizing Sofusa Lymphatic Delivery Of Etanercept
15/09/2022 14:50
Brief: Sorrento Therapeutics Inc - Entered Into A Contribution And Satisfaction Of Indebtedness Agreement With Scilex Holding Company
14/09/2022 11:09
U.S. STOCKS ON THE MOVE-Guardant Health, PayPal, Bausch Health
31/08/2022 19:03
U.S. STOCKS ON THE MOVE-Moderna, Addentax, Baxter
31/08/2022 16:57
U.S. STOCKS ON THE MOVE-Chico's FAS, Nuwellis, Toyota
31/08/2022 14:26
U.S. STOCKS ON THE MOVE-Nogin, Tesla, BioCardia
31/08/2022 12:55
Sorrento Therapeutics gains on FDA's 'fast track' tag for back pain therapy
31/08/2022 11:59
Brief: Scilex Holding Says FDA Granted Fast Track Designation For Investigational Drug Candidate SP-103
31/08/2022 04:24
Sorrento rises after promising data on lung cancer drug
23/08/2022 17:24
Brief: Sorrento Announces Significant Positive Pivotal Trial Results As Assessed By An Independent Review Committee With Matured Long-Term Follow-Up Data Of Abivertinib For Treatment Of Advanced Non-Small Cell Lung Cancer
23/08/2022 14:49
Brief: Sorrento Therapeutics announces China National Medical Products Administration (NMPA) IND Clearance of STI-1558, an oral mpro inhibitor for Phase I trial in covid-19 patients
19/08/2022 14:01
Brief: Sorrento Therapeutics Files Non-Timely 10-Q
09/08/2022 22:10
Brief: Sorrento Completes Successfully SAD Study And Initiates MAD Phase 1 Study With STI-1558
03/08/2022 14:12
Brief: Sorrento Therapeutics Announces FDA IND Clearance Of STI-1558, An Oral M(Pro) And Cathepsin L Inhibitor To Treat Covid-19
19/07/2022 19:56
Brief: Scilex Holding Company, A Sorrento Company, Has Entered A Term Sheet To Acquire Ancora Medical Inc
07/07/2022 14:34
Administration Of Ritonavir Booster
03/06/2022 14:22